Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
2014 · PLoS Biology · 251 citations
https://doi.org/10.1371/journal.pbio.1001906
I
Iftekhar Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
2.6K
Citations
25
h-index
36
i10-index
Iftekhar Khan is an academic researcher from Khyber Medical College. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Economic and Financial Impacts of Cancer & Statistical Methods in Clinical Trials. The author has an h-index of 25, co-authored 84 publications.
ORCID: 0000-0001-6041-8837Papers by this author
worksFirst-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
2012 · The Lancet Oncology · 176 citations
https://doi.org/10.1016/s1470-2045(12)70412-6
Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer
2006 · Breast Cancer Research · 85 citations
https://doi.org/10.1186/bcr1508
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
2016 · International Journal of Radiation Oncology*Biology*Physics · 43 citations
https://doi.org/10.1016/j.ijrobp.2016.03.031
Smaller sample sizes for phase II trials based on exact tests with actual error rates by trading-off their nominal levels of significance and power
2012 · British Journal of Cancer · 39 citations
https://doi.org/10.1038/bjc.2012.444
Prediction of disability-free survival in healthy older people
2022 · GeroScience · 33 citations
https://doi.org/10.1007/s11357-022-00547-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat